Topical Cycling and Systemic Eligibility in Patients With Psoriasis in Japan
Akimichi Morita, Shinichi Imafuku, Hideshi Torii, Lauren Peetluk, Siddharth Chaudhari, Hidehito Mizuma, Jing Liu · 2026
Read Topical Cycling and Systemic Eligibility in Patients With Psoriasis in Japan by Akimichi Morita, Shinichi Imafuku, Hideshi Torii, Lauren Peetluk, Siddharth Chaudhari, Hidehito Mizuma, Jing Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13555188.txt.
Description
Akimichi Morita leads a seven-author team studying cream-only treatment patterns in Japanese psoriasis care in a 2026 study. Guidelines reserve whole-body drugs for wide disease, high-impact sites, or failed creams. Claims data covered 6,361 patients who began with creams alone. A survey arm applied expert criteria for when whole-body treatment becomes due.
Fewer than one patient in ten moved to whole-body drugs during follow-up, after about two years on average. Most cycled through several cream classes first, nearly four on average. In the survey group, more than nine in ten cream-only patients already met at least one expert criterion for whole-body therapy. The authors call this undertreatment and urge clinics to apply the eligibility rules in daily practice.
Catalog record
| CREATOR | Akimichi Morita, Shinichi Imafuku, Hideshi Torii, Lauren Peetluk, Siddharth Chaudhari, Hidehito Mizuma, Jing Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |